Business
CSL (ASX:CSL) share price is now down 12% in 2 weeks
The CSL Ltd (ASX: CSL) share price seems to be stuck in the doldrums over the last couple of weeks. Shares in the biotherapeutics giant have been on the decline since the company announced its half-year results 2 weeks ago.
Interestingly, CSL reported a significant 45% increase in its net profit after tax. So why is the share price falling? As always, the devil is in the details.
Dividends cut in Aussie dollar terms
No, it’s not CSL picking favourites between the United States and Australia. Due to CSL’s operations being heavily focused in the US, most of the company’s financials are shown in US dollar terms. This causes fluctuations when interchanging between multiple currencies.
In this case, CSL declared a dividend…
-
Business10 hours agoDicker Data rides the AI trend to double digit growth
-
Business14 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business18 hours agoThis leading broker thinks the CSL share price can climb 40%
-
General23 hours agoDenmark summons US envoy over suspected influence operations in Greenland